Solasia Pharma K.K. (TYO:4597)
Japan
· Delayed Price · Currency is JPY 30.00
-1.00 (-3.23%)
Jun 13, 2025, 3:30 PM JST
Solasia Pharma K.K. Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Cash & Equivalents | 1,065 | 886 | 728 | 803 | 714 | 2,964 | Upgrade
|
| Cash & Short-Term Investments | 1,065 | 886 | 728 | 803 | 714 | 2,964 | Upgrade
|
| Cash Growth | -19.26% | 21.70% | -9.34% | 12.46% | -75.91% | -27.99% | Upgrade
|
| Receivables | 23 | 232 | 67 | 572 | 126 | 173 | Upgrade
|
| Inventory | 94 | 128 | 122 | 14 | - | 4 | Upgrade
|
| Prepaid Expenses | - | 17 | 57 | 43 | 48 | 64 | Upgrade
|
| Other Current Assets | 46 | 3 | 2 | 3 | 6 | 64 | Upgrade
|
| Total Current Assets | 1,228 | 1,266 | 976 | 1,435 | 894 | 3,269 | Upgrade
|
| Property, Plant & Equipment | 38 | 47 | 81 | 63 | 120 | 102 | Upgrade
|
| Long-Term Investments | 3 | 47 | 52 | 60 | 49 | 46 | Upgrade
|
| Other Intangible Assets | - | - | 1,117 | 1,570 | 2,079 | 2,356 | Upgrade
|
| Other Long-Term Assets | 49 | 2 | 3 | 6 | 2 | 2 | Upgrade
|
| Total Assets | 1,318 | 1,362 | 2,229 | 3,134 | 3,144 | 5,775 | Upgrade
|
| Accounts Payable | 387 | 121 | 213 | 332 | 386 | 987 | Upgrade
|
| Accrued Expenses | - | 37 | 34 | 26 | 36 | 36 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 1,000 | Upgrade
|
| Current Portion of Leases | 17 | 25 | 33 | 37 | 47 | 39 | Upgrade
|
| Other Current Liabilities | 47 | 10 | 13 | 12 | 20 | 17 | Upgrade
|
| Total Current Liabilities | 451 | 193 | 293 | 407 | 489 | 2,079 | Upgrade
|
| Long-Term Leases | - | - | 27 | - | 37 | 21 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | 22 | 53 | 18 | 11 | Upgrade
|
| Other Long-Term Liabilities | 12 | 13 | 12 | 12 | 13 | 12 | Upgrade
|
| Total Liabilities | 463 | 206 | 354 | 472 | 557 | 2,123 | Upgrade
|
| Common Stock | 2,211 | 2,211 | 1,596 | 1,436 | 2,110 | 1,402 | Upgrade
|
| Additional Paid-In Capital | 2,255 | 2,255 | 1,657 | 1,500 | 5,738 | 5,043 | Upgrade
|
| Retained Earnings | -3,570 | -3,277 | -1,336 | -223 | -5,204 | -2,726 | Upgrade
|
| Treasury Stock | -65 | -65 | -69 | -70 | -70 | -70 | Upgrade
|
| Comprehensive Income & Other | 24 | 32 | 27 | 19 | 13 | 3 | Upgrade
|
| Shareholders' Equity | 855 | 1,156 | 1,875 | 2,662 | 2,587 | 3,652 | Upgrade
|
| Total Liabilities & Equity | 1,318 | 1,362 | 2,229 | 3,134 | 3,144 | 5,775 | Upgrade
|
| Total Debt | 17 | 25 | 60 | 37 | 84 | 1,060 | Upgrade
|
| Net Cash (Debt) | 1,048 | 861 | 668 | 766 | 630 | 1,904 | Upgrade
|
| Net Cash Growth | 36.81% | 28.89% | -12.79% | 21.59% | -66.91% | -52.96% | Upgrade
|
| Net Cash Per Share | 5.00 | 4.33 | 3.97 | 5.04 | 4.84 | 16.22 | Upgrade
|
| Filing Date Shares Outstanding | 218.05 | 218.05 | 173.94 | 167.97 | 133.54 | 128.56 | Upgrade
|
| Total Common Shares Outstanding | 218.05 | 218.05 | 173.94 | 167.97 | 133.51 | 122.64 | Upgrade
|
| Working Capital | 777 | 1,073 | 683 | 1,028 | 405 | 1,190 | Upgrade
|
| Book Value Per Share | 3.92 | 5.30 | 10.78 | 15.85 | 19.38 | 29.78 | Upgrade
|
| Tangible Book Value | 855 | 1,156 | 758 | 1,092 | 508 | 1,296 | Upgrade
|
| Tangible Book Value Per Share | 3.92 | 5.30 | 4.36 | 6.50 | 3.81 | 10.57 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.